Financial Performance - The company's revenue for Q1 2023 was CNY 55,440,064.10, representing a 4.39% increase compared to CNY 53,106,464.55 in the same period last year[5]. - Net profit attributable to shareholders for Q1 2023 was CNY 9,575,298.60, a 21.11% increase from CNY 7,906,004.78 year-on-year[5]. - The basic and diluted earnings per share for Q1 2023 were both CNY 0.1185, reflecting a 0.94% increase from CNY 0.1174 in the same period last year[5]. - The net profit excluding non-recurring gains and losses was CNY 6,340,660.01, down 17.50% from CNY 7,685,745.09 in the same period last year[5]. - The total operating revenue for the first quarter was CNY 55,440,064.10, an increase of 4.38% compared to CNY 53,106,464.55 in the previous period[19]. - The total profit for the first quarter was CNY 11,041,756.84, up from CNY 9,178,658.59, indicating a growth of 20.2% year-over-year[21]. - The operating profit for the first quarter was CNY 11,043,044.54, compared to CNY 10,184,421.59 in the previous year, reflecting a growth of 8.4%[21]. Cash Flow and Assets - The net cash flow from operating activities was negative CNY 632,674.43, a decline of 104.05% compared to a positive CNY 15,610,919.58 in the previous year[5][7]. - Cash flow from operating activities showed a net outflow of CNY -632,674.43, a significant decrease from a net inflow of CNY 15,610,919.58 in the previous year[23]. - The total cash inflow from operating activities was CNY 66,226,632.51, compared to CNY 72,373,547.26 in the same period last year, indicating a decline of 8.4%[23]. - Cash flow from investing activities generated a net inflow of CNY 8,630,145.46, down from CNY 64,048,790.21 in the same period last year[24]. - The company reported cash and cash equivalents at the end of the period amounting to CNY 210,218,274.10, a decrease from CNY 637,080,557.42 at the end of the previous year[24]. - Cash and cash equivalents increased to CNY 210,777,522.66 from CNY 202,779,648.02, showing a growth of 3.92%[17]. - Inventory rose to CNY 26,853,993.22, up 29.73% from CNY 20,701,630.93 at the beginning of the year[17]. - Total assets at the end of Q1 2023 were CNY 1,011,580,716.26, a decrease of 0.53% from CNY 1,017,003,454.64 at the end of the previous year[5]. - The total assets decreased to CNY 1,011,580,716.26 from CNY 1,017,003,454.64 at the beginning of the year, a decline of 0.53%[17]. Shareholder Information - The company reported a total of 10,339 common shareholders at the end of the reporting period[9]. - The top shareholder, Zhang Jun, holds 24.29% of the shares, amounting to 19,627,034 shares[9]. - The number of restricted shares released on February 23, 2023, was 40,975,923 shares, accounting for 50.71% of the total share capital after the company's issuance[15]. - The remaining restricted shares not yet released amount to 19,627,034 shares, representing 24.29% of the total share capital after the company's issuance[15]. - The total number of shareholders who had their restricted shares released was 17[15]. - The company has a total of 60,602,957 restricted shares, with 37,827,148 shares released during the reporting period[13]. - The largest shareholder, Zhang Jun, holds 19,627,034 shares, which are restricted until February 23, 2025[13]. - The second-largest shareholder, Dingdian Investment Management, holds 7,639,054 shares, which were fully released on February 23, 2023[13]. - Guo Hongsheng, another significant shareholder, holds 3,021,550 shares, all of which are restricted until February 23, 2023[13]. - The company has not engaged in any financing or securities lending activities with its top 10 shareholders[13]. - The report indicates that the company has a consistent shareholder structure with several investment management firms involved[15]. - The company is focused on maintaining a stable capital structure while managing the release of restricted shares effectively[15]. Operating Costs and Expenses - The total operating costs amounted to CNY 47,961,292.11, up 7.06% from CNY 44,475,693.43 in the prior year[19]. - Research and development expenses were CNY 1,493,602.36, a decrease of 7.63% from CNY 1,616,947.44 in the prior year[19]. - The company reported a gross profit margin of approximately 13.36% for the quarter, compared to 16.51% in the previous period[19]. Other Information - The company received government subsidies amounting to CNY 790,620.76, which were closely related to its normal business operations[6]. - The company did not conduct an audit for the first quarter report[25].
西点药业(301130) - 2023 Q1 - 季度财报